We further identified that the high expression of HNRNPL was a powerful and independent predictor of poor patient outcome, indicating that HNRNPL mRNA level could offer potential value for early diagnosis of PC and tumor monitoring after surgery. Here, HNRNPL is linked to pachyonychia congenita.